NATICK, Mass., Nov. 14, 2024 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine™, announced its ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round ...

Colossal Biosciences, a company known for its genetic research to "de-extinct" several species thought lost to time, announced last week that it has assembled the most complete Tasmanian tiger ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Bright Minds announces that its collaborating with Firefly Neuroscience to provide a full analysis of EEG data in the BREAKTHROUGH study. Bright Minds stock soared 1,445% in a single day last week ...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing ...

Bright Minds Biosciences' BMB-101, a 5-HT2C receptor agonist, shows promise in treating drug-resistant epilepsy, with favorable Phase 1 safety and efficacy data. The company's proprietary platform ...

As of the latest data, Bright Minds Biosciences Inc boasts a market capitalization of approximately $105.157 million, with a current stock price of $28.375. Despite the company's innovative ...

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ - an innovative solution that simplifies target ...

SUGAR LAND, TX, USA I October 31, 2024 I Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive ...

Bright Minds Biosciences announced a non-brokered private placement with expected gross proceeds of $35 million. The company's stock is currently trading with a session volume of about 10.6 million.